Celnovte has consistently received excellent results in the international authoritative pathology quality assessment organizations—NordiQC Immunohistochemistry.
Last year, all antibodies submitted by Celnvote for evaluation achieved exceptional results including #HER2, #ER, #PD-L1 (TPS/CPS), #CK8/18, #PSA, #CD138, #CD5, #CD10, #MSH2, #TTF1, #p40, and #p53.
HER2
In this assessment, 419 laboratories participated, achieving a pass rate of 86%, with 53% rated as excellent.
ER
In this assessment, 440 laboratories participated, achieving a pass rate of 78%, with 22% rated as excellent.
PD-L1 (TPS/CPS)
In this assessment, 243 laboratories participated, achieving a pass rate of 69%, with 32% rated as excellent.
CK8/18
In this assessment, 282 laboratories participated, achieving a pass rate of 85%, with 65% rated as excellent.
PSA
In this assessment, 377 laboratories participated, achieving a pass rate of 85%, with 50% rated as excellent.
CD138
In this assessment, 386 laboratories participated, achieving a pass rate of 86%, with 60% rated as excellent.
CD5
In this assessment, 379 laboratories participated, achieving a pass rate of 72%, with 54% rated as excellent.
CD10
In this assessment, 403 laboratories participated, achieving a pass rate of 73%, with 48% rated as excellent.
MSH2
In this assessment, 350 laboratories participated, achieving a pass rate of 91%, with 62% rated as excellent.
TTF1
In this assessment, 401 laboratories participated, achieving a pass rate of 81%, with 71% rated as excellent.
p40
In this assessment, 343 laboratories participated, achieving a pass rate of 85%, with 60% rated as excellent.
p53
In this assessment, 372 laboratories participated, achieving a pass rate of 65%, with 29% rated as excellent.
Celnovte is commited to providing integrated pathology diagnostic solutions and better patient care!
info@celnovte.com
